Drug intelligence / Profile preview

FullerLife C60

Development stage
Unknown
Lead developer
Bioactive C60
Modality
Small Molecules
Administration
Sublingual
01

Overview

**FullerLife C60** is a branded **dietary supplement and nutraceutical product** marketed by **Bioactive C60** and **FullerLifeC60** rather than an FDA-approved pharmaceutical. Its active ingredient is **carbon 60**, a small carbon allotrope composed of 60 carbon atoms in a spherical fullerene structure. The product has been promoted in **sublingual dissolvable strip** form using highly purified, solubilized C60 and is marketed for general wellness claims such as antioxidant support, immune support, and inflammation-related benefits. Mechanistically, C60 is generally described as a **non-specific free radical scavenger antioxidant** rather than a ligand with a defined pharmacologic receptor target. Based on the provided context, the product has **not been approved by the FDA as a drug or dietary supplement**, and the FDA issued a warning letter in 2020 over marketing FullerLife C60 with unapproved disease-related claims including COVID-19-related claims.

Brand names
FullerLife C60BioActiveC60BioActiveC-60BioActiveC 60
Other names
carbon 60carbon60carbon-60C60C-60C 60buckminsterfullerenefullerene C60
02

Targets

Biological membrane lipid bilayer

Beyond the preview

Go deeper on FullerLife C60.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FullerLife C60.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call